Amrinone

• 

  Subject Areas on Research

  • A bolus dose of 1.5 mg/kg amrinone effectively improves low cardiac output state following separation from cardiopulmonary bypass in cardiac surgical patients. 
  • Amrinone in patients undergoing cardiac surgery. 
  • Amrinone therapy for congestive heart failure in outpatients with idiopathic dilated cardiomyopathy. 
  • Amrinone: its effect on vascular resistance and capacitance in human subjects. 
  • Amrinone: pharmacokinetics and pharmacodynamics. 
  • Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study. 
  • Perioperative experience with amrinone. 
  • Pharmacokinetics of amrinone during cardiac surgery. 
  • Protein synthesis-dependent potentiation by thyroxine of antiviral activity of interferon-gamma. 
  • The in vitro effects of phosphodiesterase inhibitors on the human internal mammary artery.